Working Hours

Mon - Sat 9:00 - 6:00
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION
NEOFOST 2 ML INJECTION

NEOFOST 2 ML INJECTION

Price 42.0 INR/ Vial

MOQ : 50 Vials

NEOFOST 2 ML INJECTION Specification

  • Dosage Form
  • AMPOULE
  • Packaging Type
  • AMPOULE
  • Brand Name
  • NEON
  • Pacakaging (Quantity Per Box)
  • 1
  • Life Span
  • 24 MONTHS
  • Origin of Medicine
  • INDIA
  • Drug Type
  • Injection
  • Ingredients
  • Brand Name: NEOFOST 2 ml Injection Generic Name: Fosphenytoin Sodium Injection I.P. Dosage Form: Injectable Solution Pack Size: (Specify pack, e.g., 1 Vial or 5 x 2 ml Ampoules) Manufacturer: Neon Laboratories Ltd Product Description: NEOFOST 2 ml Injection contains Fosphenytoin Sodium, a water-soluble prodrug of phenytoin used for rapid seizure management. It is commonly administered intravenously or intramuscularly in hospitals to control status epilepticus and other convulsive disorders efficiently. Key Uses: Management of status epilepticus Control of generalized tonic-clonic seizures Emergency seizure therapy in hospital settings Product Highlights: Sterile, ready-to-use injectable solution Fast-acting anticonvulsant High-quality and safe IP grade formulation Suitable for hospital and clinical use Key Benefits: Quick seizure management in emergencies Effective for generalized tonic-clonic seizures Suitable for hospital and critical care units Product Features: Sterile, ready-to-use injection High-quality IP grade formulation Safe and effective anticonvulsant therapy Ideal for hospital and institutional supply For hospital and clinical use only. Administer under medical supervision.
  • Physical Form
  • Liquid
  • Function
  • Other
  • Recommended For
  • DOCTORS
  • Dosage
  • AMPOULE
  • Dosage Guidelines
  • AS PER DOCTORS PRESCRIPTION
  • Suitable For
  • Adults
  • Quantity
  • 50 Unit
  • Storage Instructions
  • BELOW 30 DEGREE CELSIUS
 

NEOFOST 2 ML INJECTION Trade Information

  • Minimum Order Quantity
  • 50 Vials
  • Delivery Time
  • 3 Days
 

NEOFOST 2 ML INJECTION About

Brand Name: NEOFOST 2 ml Injection
Generic Name: Fosphenytoin Sodium Injection I.P.
Dosage Form: Injectable Solution
Pack Size: (Specify pack, e.g., 1 Vial or 5 x 2 ml Ampoules)
Manufacturer: Neon Laboratories Ltd

Product Description:

NEOFOST 2 ml Injection contains Fosphenytoin Sodium, a water-soluble prodrug of phenytoin used for rapid seizure management. It is commonly administered intravenously or intramuscularly in hospitals to control status epilepticus and other convulsive disorders efficiently.

Key Uses:

Management of status epilepticus

Control of generalized tonic-clonic seizures

Emergency seizure therapy in hospital settings

Product Highlights:

Sterile, ready-to-use injectable solution

Fast-acting anticonvulsant

High-quality and safe IP grade formulation

Suitable for hospital and clinical use

Key Benefits:

Quick seizure management in emergencies

Effective for generalized tonic-clonic seizures

Suitable for hospital and critical care units

Product Features:

Sterile, ready-to-use injection

High-quality IP grade formulation

Safe and effective anticonvulsant therapy

Ideal for hospital and institutional supply


For hospital and clinical use only. Administer under medical supervision.




Fast-Acting Emergency Seizure Control

NEOFOST 2 ml Injection offers doctors a quick-acting option for managing life-threatening seizures, such as status epilepticus, in emergency hospital settings. Its water-soluble form facilitates rapid uptake and therapeutic action, essential for prompt convulsive disorder control.


Ready-to-Use and Sterile

Packaged in convenient 2 ml ampoules, each dose is sterile and ready for immediate administration by healthcare professionals. This eliminates preparation time, promoting efficiency and ensuring high standards of patient care in critical situations.


Specifically Designed for Hospital Use

This injectable solution is tailored for use in hospital and institutional settings, under direct medical supervision. Its efficacy, safety, and quality make it well-suited for doctors managing acute seizure presentations and require consistent results.

FAQ's of NEOFOST 2 ML INJECTION:


Q: How should NEOFOST 2 ml Injection be administered?

A: NEOFOST 2 ml Injection must be given by a healthcare professional, either intravenously (IV) or intramuscularly (IM), depending on clinical requirements. Administration should follow a doctor's prescription and institutional protocols.

Q: What are the primary uses of NEOFOST 2 ml Injection?

A: The injection is mainly indicated for emergency control of status epilepticus and management of generalized tonic-clonic seizures in hospital or clinical environments. It is most often used when rapid seizure control is required.

Q: When is NEOFOST 2 ml Injection typically used?

A: This medication is used during acute seizure episodes, particularly when immediate action is necessary, such as in status epilepticus or uncontrolled convulsions. It is reserved for hospital or emergency situations.

Q: Where can NEOFOST 2 ml Injection be stored and for how long?

A: NEOFOST 2 ml Injection should be stored below 30C and kept in its ampoule packaging. It remains effective for up to 24 months from the manufacturing date, as indicated by the manufacturer.

Q: What is the benefit of using a sterile, ready-to-use ampoule?

A: A ready-to-use sterile ampoule ensures immediate availability in emergencies, reduces preparation errors, and guarantees safe, hygienic administration in urgent hospital scenarios.

Q: Is NEOFOST 2 ml Injection suitable for home use or self-administration?

A: No, this product is strictly intended for hospital or institutional use under the supervision of trained medical professionals. It should not be used outside clinical settings.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anaesthetics Injection Category

AXIFUR 1.5G INJECTION

AXIFUR 1.5G INJECTION

Price 283.0 INR / Pair

Minimum Order Quantity : 50 Pairs

Quantity : 1 vial Boxes

Ingredients : Brand Name: AURACT 1 G Injection Generic Name / Content: Ceftriaxone Sodium Injection I.P. 1 AURACT 1 G Injection contains Ceftriaxone Sodium, a thirdgeneration cephalosporin antibiotic with broadspectrum activity against Grampositive and Gramnegative bacteria. It is widely used for the treatment of serious bacterial infections in hospital and clinical settings. Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial death. This injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration under medical supervision. Indications Respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Septicemia and bacteremia Bone and joint infections Meningitis Gonorrhea and other sexually transmitted infection Key Features Thirdgeneration cephalosporin antibiotic Broadspectrum antibacterial activity Rapid and effective action Sterile injectable form for IV or IM use Suitable for adults and pediatric patients (as prescribed) Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Strength: 1 g per vial Content: Ceftriaxone Sodium I.P. Packaging & Storage Supplied in sterile vials Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Drug Type : Injection

Physical Form : Other

CEFTRAX 250MG INJECTION

CEFTRAX 250MG INJECTION

Price 27.0 INR / Box

Minimum Order Quantity : 50 Pieces

Quantity : 50 Pieces

Ingredients : Brand Name: CEFTRAX 250 mg Generic Name / Content: Ceftriaxone Injection I.P. 250 mg Company: Aurobindo Pharma Lt CEFTRAX 250 mg Injection contains Ceftriaxone, a thirdgeneration cephalosporin antibiotic used to treat a wide range of bacterial infections. It works by inhibiting bacterial cell wall synthesis, resulting in the death of susceptible bacteria. This sterile injectable formulation is intended for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings. Indications Respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Septicemia and bacteremia Meningitis Gonorrhea and other sexually transmitted infections Surgical prophylaxis Key Features Thirdgeneration cephalosporin antibiotic Broadspectrum activity against Grampositive and Gramnegative bacteria Rapid and effective action Sterile injectable form suitable for IV or IM use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Antibiotic Strength: 250 mg per vial Content: Ceftriaxone I.P. Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Drug Type : Injection

Physical Form : Liquid

ROPIN 0.20% 50ML

ROPIN 0.20% 50ML

Price 306.5 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 50 Unit

Ingredients : ROPIN 0.20% 50ML Ropivacaine Hydrochloride Injection I.P. Brand: ROPIN Injection Content: Ropivacaine Hydrochloride I.P. 0.2% w/v (2 mg / ml) Company / Manufacturer: Neon Laboratories Ltd Pack: 50 ml Vial Category: Local Anesthetic / AmideType Regional AnestheticProduct Description ROPIN 0.20% 50ml Vial contains Ropivacaine Hydrochloride, a longacting amidetype local anesthetic solution formulated for parenteral administration. The 0.2% concentration is specifically designed to provide effective sensory nerve blockade while minimizing motor block, making it ideal for continuous pain relief. It is widely used in postoperative wards, intensive care units, and delivery rooms to provide stable, longlasting regional pain control during surgical recovery or childbirth with enhanced systemic safety margins.Key Uses Production of continuous epidural infusion analgesia for labor pain management during childbirth Postoperative pain management following major orthopedic, abdominal, or thoracic surgeries Continuous peripheral nerve blocks and infiltration anesthesia for local pain control Longterm acute pain management in intensive care settings How It Works Ropivacaine works by blocking the generation and conduction of nerve impulses. It diffuses into the nerve sheath and binds selectively to the intracellular sodium channels of nerve fibers. This action prevents the influx of sodium ions through the cell membrane, stopping the electrical depolarization of the nerve cell. By blocking these pathways, the drug temporarily prevents pain signals from traveling from the affected site up the spinal cord to the brain.Directions for Use Administer via epidural infusion, peripheral nerve block, or local tissue infiltration routes Visually check the solution inside the vial for any particles, leaks, or cloudiness before extraction Extract using clean, sterile syringes directly through the rubber stopper core Must be calculated, handled, and administered exclusively by a registered anesthesiologist or clinician Key Features Optimized concentration that provides reliable pain relief with minimal loss of skeletal muscle control Extended therapeutic window that delivers prolonged postsurgical and labor analgesia High volume 50 ml vial format designed to support continuous infusion pumps or repeated dosing protocols Fabricated under international sterile manufacturing standards by Neon Laboratories Ltd Possible Side Effects Hypotension or sudden temporary drop in systemic blood pressure Nausea, vomiting, or mild dizziness Important Safety Notes Storage Temperature: Store below 30 C in a cool, dry place. Protect from direct light lines and do not freeze. For local and regional blocks only; strictly contraindicated for intravenous regional anesthesia methods Avoid application directly into highly inflamed or infected tissue surfaces Schedule H Prescription Drug: Restricted for institutional supply to verified buyers with drug wholesale licenses

Drug Type : Injection

Physical Form : Liquid

Cisatracurium Besylate Injection USP

Cisatracurium Besylate Injection USP

Price 319 INR / Vial

Minimum Order Quantity : 100 Vials

Quantity : 1 Pieces

Drug Type : Injection

Physical Form : Liquid



Back to top